Cargando…

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters

Neurofilament light is a constituent of the neuronal cytoskeleton and released into the blood following neuro-axonal damage. It has previously been reported that NfL measured in blood serum is inversely related to body mass index. However, no reports exist with regard to body composition assessed us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermesdorf, Marco, Leppert, David, Maceski, Aleksandra, Benkert, Pascal, Wellmann, Jürgen, Wiendl, Heinz, Kuhle, Jens, Berger, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508163/ https://www.ncbi.nlm.nih.gov/pubmed/36151266 http://dx.doi.org/10.1038/s41598-022-20398-y

Ejemplares similares

Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study
por: Rübsamen, Nicole, et al.
Publicado: (2021)

Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
por: Herrera-Rivero, Marisol, et al.
Publicado: (2023)

A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies
por: Rübsamen, Nicole, et al.
Publicado: (2022)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019)

Neurofilament light chain predicts future dementia risk in cerebral small vessel disease
por: Egle, Marco, et al.
Publicado: (2021)

Development of an age‐adjusted model for blood neurofilament light chain
por: Harp, Christopher, et al.
Publicado: (2022)

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS
por: Kuhle, Jens, et al.
Publicado: (2021)

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
por: Ameres, Markus, et al.
Publicado: (2020)

Factors influencing serum neurofilament light chain levels in normal aging
por: Koini, Marisa, et al.
Publicado: (2021)

A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users
por: Bavato, Francesco, et al.
Publicado: (2023)

Serum neurofilament light levels in normal aging and their association with morphologic brain changes
por: Khalil, Michael, et al.
Publicado: (2020)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants
por: Goeral, Katharina, et al.
Publicado: (2021)

Serum Neurofilament Light Chain: A Marker of Nervous System Damage in Myopathies
por: Saak, Annika, et al.
Publicado: (2021)

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
por: Delcoigne, Bénédicte, et al.
Publicado: (2020)

Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome
por: Körtvelyessy, Peter, et al.
Publicado: (2020)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Long-term prognostic value of longitudinal measurements of blood neurofilament levels
por: Häring, Dieter A., et al.
Publicado: (2020)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
por: Depoorter, Antoinette, et al.
Publicado: (2018)

Serum neurofilament light chains in MS: Association with the Timed Up and Go
por: Allali, Gilles, et al.
Publicado: (2020)

Serum Neurofilament Levels in Children With Febrile Seizures and in Controls
por: Evers, Katrina S., et al.
Publicado: (2020)

Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study
por: Hunziker, Sabina, et al.
Publicado: (2021)

Association of serum neurofilament light with microglial activation in multiple sclerosis
por: Saraste, Maija, et al.
Publicado: (2023)

Neurofilament Light Chain serum levels after Hypoxia-Ischemia in a newborn piglet model
por: Kyng, Kasper Jacobsen, et al.
Publicado: (2023)

Neurofilament light chain plasma levels are associated with area of brain damage in experimental cerebral malaria
por: Wai, Chi Ho, et al.
Publicado: (2022)

Bioelectrical impedance phase angle as a prognostic indicator in breast cancer
por: Gupta, Digant, et al.
Publicado: (2008)

Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
por: Maggi, Pietro, et al.
Publicado: (2021)

Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2020)

Bioelectrical impedance analysis in ICU patients
por: Steinhilp, L, et al.
Publicado: (2009)

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
por: Sormani, Maria Pia, et al.
Publicado: (2019)

Serum neurofilament light chain as outcome marker for intensive care unit patients
por: Fisse, Anna Lena, et al.
Publicado: (2020)

High serum neurofilament associates with diffuse white matter damage in MS
por: Saraste, Maija, et al.
Publicado: (2020)

The Possibility of Using Bioelectrical Impedance Analysis in Pregnant and Postpartum Women
por: Obuchowska, Aleksandra, et al.
Publicado: (2021)

Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome
por: Fabis‐Pedrini, Marzena J., et al.
Publicado: (2022)

Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
por: Margraf, Nils G., et al.
Publicado: (2023)

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
por: Kuhle, Jens, et al.
Publicado: (2019)

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rthklk5s0ho8qvjc3rk5d0i9gb